Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH
CAS No. 120173-57-1
Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH( Fmoc-Ser-(GalNAc(Ac)3-alpha-D)-OH | Fmoc-Ser[GalNAc(Ac)3-α-D]-OH | Fmoc-Ser(Ac3AcNH-α-Gal)-OH )
Catalog No. M20913 CAS No. 120173-57-1
Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH is an anti-tumor drug.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 39 | Get Quote |
|
| 5MG | 61 | Get Quote |
|
| 10MG | 87 | Get Quote |
|
| 25MG | 160 | Get Quote |
|
| 50MG | 259 | Get Quote |
|
| 100MG | 419 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameFmoc-Ser(O-α-D-GalNAc(OAc)3)-OH
-
NoteResearch use only, not for human use.
-
Brief DescriptionFmoc-Ser(O-α-D-GalNAc(OAc)3)-OH is an anti-tumor drug.
-
DescriptionFmoc-Ser(O-α-D-GalNAc(OAc)3)-OH is an anti-tumor drug.
-
In Vitro——
-
In Vivo——
-
SynonymsFmoc-Ser-(GalNAc(Ac)3-alpha-D)-OH | Fmoc-Ser[GalNAc(Ac)3-α-D]-OH | Fmoc-Ser(Ac3AcNH-α-Gal)-OH
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number120173-57-1
-
Formula Weight656.63
-
Molecular FormulaC32H36N2O13
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (152.29 mM)
-
SMILESCC(=O)N[C@H]1[C@@H](OC[C@H](NC(=O)OCC2c3ccccc3-c3ccccc32)C(=O)O)O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Eberling J Braun P Kowalczyk D et al. ChemInform Abstract: Chemoselective Removal of Protecting Groups from O‐Glycosyl Amino Acid and Peptide (Methoxyethoxy)ethyl Esters Using Lipases and Papain.[J]. ChemInform 1996 27.
molnova catalog
related products
-
Apigenin-6-C-beta-D-...
The herbs of Chrysanthemi indici L.
-
7-Methyladenine
7-Methyladenine can be used as a marker of exposure to exogenous and carcinogenic methylating agents.
-
LEM-14-1189 B
Lem-14-1189, a LEM-14 derivative, is a potent NSD inhibitor of the nuclear receptor binding SET domain, and has inhibitory effects on NSD1, NSD2, and NSD3, with IC50 of 418 μM, 111 μM, and 60 μM, respectively.
Cart
sales@molnova.com